Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             62 results found
no title author magazine year volume issue page(s) type
1 Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going? Le Chevalier, T.

21 S7 p. vii196-vii198
article
2 Advances in neuroendocrine lung tumors Travis, W.D.

21 S7 p. vii65-vii71
article
3 Advances in systemic treatment of melanoma Eggermont, A.M.M.

21 S7 p. vii339-vii344
article
4 Advances in the treatment of metastatic or unresectable biliary tract cancer Valle, J.W.

21 S7 p. vii345-vii348
article
5 Anemia in cancer Dicato, M.

21 S7 p. vii167-vii172
article
6 Benefits and adverse effects of endocrine therapy Colleoni, M.

21 S7 p. vii107-vii111
article
7 Cancer of unknown primary site: 20 questions to be answered Pavlidis, N.

21 S7 p. vii303-vii307
article
8 Cancer stem cells Cordon-Cardo, C.

21 S7 p. vii93-vii94
article
9 Cardiotoxicity Brana, I.

21 S7 p. vii173-vii179
article
10 Chemotherapy: which drug and when? Sobrero, A.

21 S7 p. vii130-vii133
article
11 Chemotherapy with or without trastuzumab Oakman, C.

21 S7 p. vii112-vii119
article
12 Chronic lymphocytic leukemia Hallek, Michael

21 S7 p. vii154-vii164
article
13 Circulating cancer cells Mavroudis, D.

21 S7 p. vii95-vii100
article
14 Consequences of targeted treatments for second-line therapy De Maio, E.

21 S7 p. vii234-vii240
article
15 Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer? Konopa, K.

21 S7 p. vii199-vii202
article
16 Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging Vansteenkiste, J.

21 S7 p. vii189-vii195
article
17 Editorial Board
21 S7 p. ii-iii
article
18 ESMO Education
21 S7 p. vii5-vii7
article
19 ESMO Educational and Scientific activities
21 S7 p. vii10-vii11
article
20 ESMO Fellowship Program
21 S7 p. vii12-vii16
article
21 ESMO-MORA
21 S7 p. vii8-vii9
article
22 European Society for Medical Oncology Committees
21 S7 p. vii18-vii19
article
23 Follicular lymphoma Ghielmini, M.

21 S7 p. vii151-vii153
article
24 Gastrointestinal neuroendocrine tumors Öberg, K.E.

21 S7 p. vii72-vii80
article
25 Genetic counselling for hereditary predisposition to ovarian and breast cancer Mackay, J.

21 S7 p. vii334-vii338
article
26 Histology-driven chemotherapy of soft-tissue sarcoma Eriksson, M.

21 S7 p. vii270-vii276
article
27 Horizon scanning for novel therapeutics for the treatment of prostate cancer Bianchini, D.

21 S7 p. vii43-vii55
article
28 How to integrate current knowledge in selecting patients for first line in NSCLC? Felip, E.

21 S7 p. vii230-vii233
article
29 How to integrate molecular targeted agents in the continuum of care Köhne, C.-H.

21 S7 p. vii134-vii139
article
30 How to select targeted therapy in renal cell cancer Escudier, B.

21 S7 p. vii59-vii62
article
31 Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer Posner, M.R.

21 S7 p. vii246-vii251
article
32 Introduction from the ESMO 2010 Educational Committee Chair
21 S7 p. vii24
article
33 Is there any role for surgery in the multidisciplinary treatment of esophageal cancer? Stahl, M.

21 S7 p. vii283-vii285
article
34 Merkel cell carcinoma Becker, J.C.

21 S7 p. vii81-vii85
article
35 Mesothelioma Weder, W.

21 S7 p. vii326-vii333
article
36 Multimodality treatment for localized gastro-oesophageal cancer Okines, A.F.C.

21 S7 p. vii286-vii293
article
37 Multiple myeloma Dimopoulos, M.A.

21 S7 p. vii143-vii150
article
38 Multiple myeloma Bladé, J.

21 S7 p. vii313-vii319
article
39 Nasopharyngeal carcinoma Chan, A.T.C.

21 S7 p. vii308-vii312
article
40 New agents for bladder cancer Bellmunt, J.

21 S7 p. vii56-vii58
article
41 New trends for staging and therapy for localized gastroesophageal cancer: the role of PET Lordick, F.

21 S7 p. vii294-vii299
article
42 Optimal treatment for recurrent/metastatic head and neck cancer Vermorken, J.B.

21 S7 p. vii252-vii261
article
43 Optimal treatment for relapsing ovarian cancer Ledermann, J.A.

21 S7 p. vii218-vii222
article
44 Osteosarcoma Ritter, J.

21 S7 p. vii320-vii325
article
45 Prevention and treatment of side-effects of systemic treatment: bone loss Body, J.-J.

21 S7 p. vii180-vii185
article
46 Proteomics as a guiding tool for more effective personalized therapy Lee, J.-M.

21 S7 p. vii205-vii210
article
47 Should we continue to use the term non-small-cell lung cancer? Gazdar, A.F.

21 S7 p. vii225-vii229
article
48 Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies Wardelmann, E.

21 S7 p. vii265-vii269
article
49 Table of Contents
21 S7 p. v-vi
article
50 Targeted therapies in soft tissue sarcomas Judson, I.

21 S7 p. vii277-vii280
article
51 The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer Bookman, M.A.

21 S7 p. vii211-vii217
article
52 The epithelial–mesenchymal transition (EMT) phenomenon Savagner, P.

21 S7 p. vii89-vii92
article
53 The role of human papillomavirus infection in head and neck cancers Syrjänen, S.

21 S7 p. vii243-vii245
article
54 35th ESMO Congress Officers
21 S7 p. vii20-vii21
article
55 35th ESMO Congress Organization
21 S7 p. vii22-vii23
article
56 Title Page
21 S7 p. iv
article
57 Treatment of HER2-overexpressing breast cancer Baselga, J.

21 S7 p. vii36-vii40
article
58 Treatment of pT1N0 breast cancer: multigene predictors to assess risk of relapse Fumagalli, D.

21 S7 p. vii103-vii106
article
59 Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization? Berrada, N.

21 S7 p. vii30-vii35
article
60 What can the molecular pathologist offer for optimal decision making? Richman, S.D.

21 S7 p. vii123-vii129
article
61 What can the pathologist offer for optimal treatment choice? Viale, G.

21 S7 p. vii27-vii29
article
62 Young Oncologists
21 S7 p. vii17
article
                             62 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands